Investing in Longevity & The Science of Aging | #𝗦𝗔𝗟𝗧𝗡𝗬

TL;DR

The interview discusses the science of longevity and the development of drugs that can prevent multiple diseases associated with aging, ultimately leading to a longer and healthier lifespan.

Transcript

foreign okay great welcome everybody my name is I have the huge pleasure to interview my colleagues so we started a company together Cambrian biopharma about yeah the title says actually the science of Aging uh hopefully it's more the science of not aging because that's all about but meaning first maybe big question is um how would because it's suc... Read More

Key Insights

• 🤕 The science of longevity is focused on developing drugs that can prevent multiple age-related diseases simultaneously.
• 🎯 The first drugs targeted at the drivers of aging are entering phase two clinical trials.
• 🤕 The timeline for regulatory approval of aging drugs may vary depending on different jurisdictions.
• ⌛ The investment potential for longevity drugs is significant, with the potential to create the best-selling medicine of all time.
• 🪡 There is a need to shift from focusing solely on lifespan to maximizing Health Span, the number of healthy years individuals have.
• 🤕 Longevity drugs can have immediate value by targeting specific diseases before addressing aging directly.
• 🥺 The gradual increase in life expectancy through longevity interventions can lead to a progressive prevention approach, where more innovations can be developed to further extend health span.

Questions & Answers

Q: What is the focus of research in the field of longevity and aging?

The focus is on the development of drugs that can prevent multiple age-related diseases at the same time, such as cancer, heart disease, and frailty.

Q: When can we expect these longevity drugs to be available?

The first approvals of these drugs may happen in the late 2020s or early 2030s, depending on regulatory paths in different jurisdictions.

Q: What is the investment potential for longevity drugs?

Creating a drug that slows down aging would be highly profitable, but it may take time. In the meantime, individual disease-targeted drugs can still provide significant value in the market.

Q: What are some practical things individuals can do to increase their chances of benefiting from future longevity drugs?

Focus on practicing good sleep habits, maintaining a healthy diet such as the Mediterranean diet, exercising regularly, and fostering a sense of community and purpose.

Summary & Key Takeaways

• The progress in the field of longevity is focused on developing drugs that can prevent multiple diseases, such as cancer, heart disease, and frailty, simultaneously.

• The first drugs targeted at the drivers of aging are entering phase two clinical trials, and regulatory approval for aging drugs might be expected in the late 2020s or early 2030s.

• The investment case for longevity drugs sits in the potential for creating a drug that slows down aging, which would be highly profitable, but it may take time to achieve. In the meantime, individual disease-targeted drugs can provide immediate value to the market.